CANCvsIWM
Tema Oncology ETF against iShares Russell 2000 ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| CANC | IWM | |
|---|---|---|
| Expense ratio | 0.99% | 0.19% |
| Assets | $51M | $76.6B |
| Net flow, 1 month | — | −$4.3B |
| Net flow, 1 year | — | −$3.3B |
| Return, YTD | +16.0% | +10.9% |
| Return, 1 year | — | — |
| Avg daily volume | 19K | 23.5M |
| Holdings | 56 | 1970 |
| Listed | Aug 14, 2023 | May 22, 2000 |
| Options market | No | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS